PD1/PD-L1 Expression in Blastic Plasmacytoid Dendritic Cell Neoplasm

Patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN) have poor outcomes despite intensive chemotherapy, underscoring the need for novel therapeutic approaches. The expression status of PD1/PD-L1 in BPDCN remains unknown. We evaluated PD1/PD-L1 by immunohistochemistry and RNAseq express...

Descripción completa

Detalles Bibliográficos
Autores principales: Aung, Phyu P., Sukswai, Narittee, Nejati, Reza, Loghavi, Sanam, Chen, Weina, Torres-Cabala, Carlos A., Yin, C. Cameron, Konopleva, Marina, Zheng, Xiaofeng, Wang, Jing, Tang, Zhenya, Medeiros, L. Jeffrey, Prieto, Victor G., Pemmaraju, Naveen, Khoury, Joseph D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562447/
https://www.ncbi.nlm.nih.gov/pubmed/31109153
http://dx.doi.org/10.3390/cancers11050695

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562447/
https://www.ncbi.nlm.nih.gov/pubmed/31109153
http://dx.doi.org/10.3390/cancers11050695

Ejemplares similares